REFERENCES
- Bruera E. Palliative sedation: When and how. J Clin. Oncol. 2012 April 20;30(12):1258–9.
- Elsayem A, Curry E III, Boohene J, Use of palliative sedation for intractable symptoms in the palliative care unit of a comprehensive cancer center. Support Care Cancer. 2009;17:53–9.
- Maltoni M, Scarpi E, Rosati M, Palliative sedation in end-of-life care and survival: A systematic review. J Clin Oncol. 2012;30:1378–83.
- Cherny NI, Portenoy RK. Sedation in the management of refractory symptoms: Guidelines for evaluation and treatment. J Palliat Care. 1994;10:31–8.
- Mercadante S, Intravaia G, Villari P, Controled sedation for refractory symptoms in dying patients. J Pain Symptom Manage. 2009;37:771–9.
- Caraceni A, Zecca E, Martini C, Palliative sedation at the end of life at a tertiary cancer center. Support Care Cancer. 2012 Jun;20(6):1299–307.
- Mercadante S, Porzio G, Valle A, Home Care–Italy Group (HOCAI). Palliative sedation in advanced cancer patients followed at home: a retrospective analysis. J Pain Symptom Manage. 2012 Jun;43(6):1126–30.
- Cancelli F., et Filbet M., La sédation en phase terminale: une expérience à domicile. INFOKara 2002/3;17:86–92.
- Pisani F, Oteri G, Costa C, Di Raimondo G, Di Perri R. Effects of psychotropic drugs on seizure threshold. Drug Saf. 2002;25(2):91–110.
- Breitbart W, Marotta R, Platt MM, Weisman H, Derevenco M, Grau C, A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatr. 1996;153:231–7.